Integrating AI vendor audits into the overall supplier quality program Integrating AI vendor audits into the overall supplier quality program Regulatory Affairs Context The rapid evolution of artificial intelligence (AI) and machine learning (ML) technologies has significantly altered how pharmaceutical and biotechnology companies conduct their operations, especially with regards to quality systems. As organizations increasingly rely on AI-driven platforms for various functions, including drug development, manufacturing, and quality control, the need for robust regulatory oversight becomes paramount. Regulatory Affairs (RA) professionals face challenges in ensuring that AI vendors comply with established Good Practice (GxP) standards, maintain data integrity, and maximize…

Handling Major Vendor Changes in AI Models and Infrastructure Handling Major Vendor Changes in AI Models and Infrastructure The increasing integration of Artificial Intelligence (AI) and Machine Learning (ML) into quality systems, particularly within the pharmaceutical and biotech sectors, has raised considerable regulatory concerns. This article aims to provide a comprehensive guide for regulatory professionals on managing significant vendor changes in AI models and infrastructures, emphasizing the regulatory framework, guidelines, and agency expectations across the US, UK, and EU. Regulatory Affairs Context Regulatory Affairs (RA) is fundamentally concerned with ensuring that pharmaceutical and biotech products are compliant with the varying…

Global considerations for cross border data and AI vendor hosting Global considerations for cross border data and AI vendor hosting The integration of Artificial Intelligence (AI) and Machine Learning (ML) in quality systems has necessitated a substantive shift in regulatory affairs, particularly concerning vendor qualification audits. Regulatory professionals in the pharmaceutical and biotech industries must navigate complex landscapes governed by numerous guidelines, regulations, and agency expectations across the US, UK, and EU jurisdictions. Context Cross-border data management and the utilization of AI in Quality Management Systems (QMS) introduces specific regulatory challenges. These extend beyond classic data governance to include compliance…

Training Audit Teams on Technical Topics in AI and ML Platforms Training Audit Teams on Technical Topics in AI and ML Platforms Regulatory Affairs Context As the integration of Artificial Intelligence (AI) and Machine Learning (ML) technologies in the pharmaceutical and biotech sectors accelerates, so do the regulatory expectations surrounding these innovations. The necessity for robust vendor qualification audits becomes paramount, not only to maintain compliance but also to ensure data integrity and algorithm transparency. Regulatory Affairs (RA) professionals must be adept in navigating these complex landscapes to facilitate adequate oversight of GxP suppliers and their AI/ML quality platforms. Legal/Regulatory…

Governance Committees for Approving High Risk AI Vendor Deployments Governance Committees for Approving High Risk AI Vendor Deployments The integration of Artificial Intelligence (AI) into quality systems presents unique challenges for regulatory affairs (RA) professionals, particularly in the context of vendor qualification and audits. As organizations increasingly adopt AI-driven solutions, ensuring compliance with Good Practice (GxP) guidelines, data integrity, and algorithm transparency becomes imperative. This article outlines the framework for governance committees tasked with overseeing the qualification of AI vendors and approving high-risk AI implementations within pharma and biotech environments. Regulatory Context AI technologies within the healthcare sector, particularly those…